Cabaletta Bio, Inc. (CABA) Form 10-Q Quarterly Reports
Cabaletta Bio, Inc. (CABA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CABA
CIK: 1759138
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerStephen Matsick
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001759138-26-000041 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003687 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001897612-26-000608 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-350333 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001759138-26-000039 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001759138-26-000038 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000919574-26-004972 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-12 | — | SCHEDULE 13G Filing | 0001374170-26-000058 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001326 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002220 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-23 | — | SCHEDULE 13G/A Filing | 0001104659-26-086361 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-09 | 8-K | 0001759138-26-000033 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | 4 | 0001193125-26-266239 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | 4 | 0001193125-26-266232 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | 4 | 0001193125-26-266229 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | 4 | 0001193125-26-266224 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | 4 | 0001193125-26-266220 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-05 | — | SCHEDULE 13G/A Filing | 0001137774-26-000127 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-04 | — | SCHEDULE 13G/A Filing | 0000053417-26-000042 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | 8-K | 0001759138-26-000030 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-01 | — | DEFA14A | 0001193125-26-249726 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002219 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001759138-26-000026 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001759138-26-000025 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001759138-26-000024 | View SEC Doc Filr Page |